Sage Rhino Capital LLC Merck & Co., Inc. Transaction History

Sage Rhino Capital LLC

$439 Million
Q3 2024

A detailed history of Sage Rhino Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sage Rhino Capital LLC holds 10,547 shares of MRK stock, worth $1.05 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

10,547

Previous 10,606 0.56%

Holding current value

$1.05 Million

Previous $1.31 Million 8.83%

% of portfolio

0.27%

Previous 0.32%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$111.15 - $128.97 $6,557 - $7,609	-59 Reduced 0.56%	10,547 $1.2 Million
Q2 2024 Jul 30, 2024	SELL	$123.8 - $132.96 $247 - $265	-2 Reduced 0.02%	10,606 $1.31 Million
Q1 2024 Apr 26, 2024	BUY	$113.24 - $131.95 $22,761 - $26,521	201 Added 1.93%	10,608 $1.4 Million
Q4 2023 Feb 05, 2024	SELL	$100.18 - $109.02 $1,302 - $1,417	-13 Reduced 0.12%	10,407 $1.13 Million
Q3 2023 Oct 26, 2023	BUY	$102.95 - $114.33 $3,191 - $3,544	31 Added 0.3%	10,420 $1.07 Million
Q2 2023 Jul 31, 2023	SELL	$108.61 - $118.38 $3,909 - $4,261	-36 Reduced 0.35%	10,389 $1.2 Million
Q1 2023 Apr 20, 2023	SELL	$102.94 - $114.86 $12,661 - $14,127	-123 Reduced 1.17%	10,425 $1.11 Million
Q4 2022 Jan 31, 2023	BUY	$87.44 - $112.11 $2,098 - $2,690	24 Added 0.23%	10,548 $1.17 Million
Q3 2022 Oct 24, 2022	SELL	$84.53 - $94.96 $6,339 - $7,121	-75 Reduced 0.71%	10,524 $906,000
Q2 2022 Jul 28, 2022	BUY	$83.49 - $94.64 $11,271 - $12,776	135 Added 1.29%	10,599 $966,000
Q1 2022 Apr 27, 2022	BUY	$73.51 - $82.4 $3,528 - $3,955	48 Added 0.46%	10,464 $859,000
Q4 2021 Feb 04, 2022	BUY	$72.28 - $90.54 $4,553 - $5,704	63 Added 0.61%	10,416 $798,000
Q3 2021 Oct 18, 2021	BUY	$71.68 - $78.83 $4,515 - $4,966	63 Added 0.61%	10,353 $778,000
Q2 2021 Jul 27, 2021	BUY	$70.31 - $77.77 $10,757 - $11,898	153 Added 1.51%	10,290 $800,000
Q1 2021 May 04, 2021	SELL	$68.86 - $81.11 $550 - $648	-8 Reduced 0.08%	10,137 $781,000
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $4,808 - $5,336	67 Added 0.66%	10,145 $830,000
Q3 2020 Nov 05, 2020	BUY	$73.18 - $82.95 $1,390 - $1,576	19 Added 0.19%	10,078 $836,000
Q2 2020 Jul 30, 2020	SELL	$70.42 - $80.13 $985 - $1,121	-14 Reduced 0.14%	10,059 $778,000
Q1 2020 Apr 29, 2020	SELL	$63.36 - $87.82 $3,421 - $4,742	-54 Reduced 0.53%	10,073 $775,000
Q4 2019 Jan 31, 2020	BUY	$77.58 - $87.54 $3,801 - $4,289	49 Added 0.49%	10,127 $907,000
Q3 2019 Oct 25, 2019	BUY	$76.08 - $82.93 $2,282 - $2,487	30 Added 0.3%	10,078 $848,000
Q2 2019 Aug 20, 2019	BUY	$69.84 - $81.59 $69 - $81	1 Added 0.01%	10,048 $843,000
Q1 2019 Apr 18, 2019	BUY	$69.58 - $79.36 $699,070 - $797,329	10,047 New	10,047 $836,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Merck & Co., Inc. Transaction History